GeneDx investors face August 3, 2026 lead plaintiff deadline in WGS lawsuit
Robbins Geller says the case alleges GeneDx misled investors about Fabric Genomics before reporting a margin drop, lower 2026 earnings guidance and a $31.3 million impairment loss.